Categorie -wet- en regelgeving

bv CGR, GDPR

wet- en regelgeving

AbbVie submits migraine prevention drug to EMA for marketing authorisation

21 juli 2022

PMLiVE

wet- en regelgeving

Mixed Results for Paxlovid in Standard Risk Patients With COVID-19

21 juni 2022

Monthly Prescribing Reference (MPR): Drugs in the Pipeline

wet- en regelgeving

Nederlandse reactie op gerichte consultatie over herziening EMA-vergoedingensysteem

6 juni 2022

rijksoverheid.nl

wet- en regelgeving

Ahead of ASCO meet, two oncology upstarts run into difficulty

6 juni 2022

MMM - Medical Marketing and Media

wet- en regelgeving

Sanofi and Regeneron receive FDA approval for eosinophilic oesophagitis treatment

23 mei 2022

PMLiVE

wet- en regelgeving

AstraZeneca’s COVID-19 vaccine receives EMA approval for use as third-dose booster

23 mei 2022

PMLiVE

Medhc-fases-banner

Advertentie(s)

Copyright 2023 © Uitgave van MedHealth Communications BV | Privacy disclaimer